Advertisement

Topics

Algeta ASA Company Profile

05:20 EDT 24th September 2018 | BioPortfolio

Algeta was founded in 1997 (as Anticancer Therapeutic Inventions) based upon a unique combination of radiation chemistry, nuclear medicine and clinical oncology expertise brought together by its two founders, Dr. Roy H. Larsen and Professor عvind S. Bruland.
Algeta's vision is to build upon this intellectual property base to establish itself as a pre-eminent global company focused on the discovery and development of novel radiopharmaceuticals for oncology.

In particular, Algeta has established itself as a world-leading source of innovation in the field of alpha emitting radiopharmaceuticals and is the first company in the world to enter clinical trials for the therapeutic treatment of cancer with an alpha particle emitter.

Algeta intends to aggressively capitalize on the commercial opportunities that result from this leadership position.

Algeta is a company focused on developing novel targeted therapies for patients with cancer based on its alpha-pharmaceutical platform. The Company is headquartered in Oslo, Norway, and has a US subsidiary, Algeta US, LLC, based in Cambridge, MA performing commercial marketing operations in the US. Algeta is listed on the Oslo Stock Exchange (Ticker: ALGETA).

Research  Technology:

  • Radium-223
  • Thorium-227

Location

Kjelsasveien 172 A, PO Box 54
Kjelsas
Oslo
NO-0411
Norway

Contact

Phone: 47 23 00 79 90
Fax: 47 23 00 79 91
Email: post@algeta.com


News Articles [1 Associated News Articles listed on BioPortfolio]

PTV News: Sep 8, 2009

Top stories on September 8th, 2009: The new man at the helm of Roche's drugs division Hopes raised for an HIV vaccine Bayer's deal with Noway's Algeta Obama's make or break speech on healthcare re...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [2 Associated Companies listed on BioPortfolio]

Algeta

Algeta ASA is a cancer therapeutics company built on world-leading, proprietary technology. Algeta is developing a new generation of targeted cancer therapeutics (alpha-pharmaceuticals) that harne...

Algeta ASA

Algeta was founded in 1997 (as Anticancer Therapeutic Inventions) based upon a unique combination of radiation chemistry, nuclear medicine and clinical oncology expertise brought together by its two...

More Information about "Algeta ASA" on BioPortfolio

We have published hundreds of Algeta ASA news stories on BioPortfolio along with dozens of Algeta ASA Clinical Trials and PubMed Articles about Algeta ASA for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Algeta ASA Companies in our database. You can also find out about relevant Algeta ASA Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Corporate Database Quicklinks



Searches Linking to this Company Record